Table 3.
Before the first stage | After the first stage | After the second stage | |
---|---|---|---|
CRP (mg/L) | |||
Treatment regimen A | 30.21 ± 6.98 | 27.33 ± 6.23a | 29.96 ± 6.21 |
Treatment regimen B | 30.03 ± 8.33 | 29.55 ± 7.71 | 26.83 ± 6.08 |
VEGF (pg/ml) | |||
Treatment regimen A | 180.22 ± 18.51 | 178.32 ± 16.10b | 179.63 ± 17.59 |
Treatment regimen B | 182.87 ± 23.31 | 183.12 ± 21.40c | 180.45 ± 20.49 |
RI (0~1) | |||
Treatment regimen A | 0.53 ± 0.05 | 0.85 ± 0.04d | 0.63 ± 0.04 |
Treatment regimen B | 0.54 ± 0.05 | 0.55 ± 0.06 | 0.83 ± 0.04 |
CRP C-reactive protein, VEGF vascular endothelial growth factor, RI resistance index
aCompared with that before the first stage (P = 0.032)
bCompared with that before the first stage (P = 0.230)
cCompared with that before the first stage (P = 0.120)
dCompared with that before the first stage (P < 0.001)